TE
TED.F TerrAscend Corp
- Market cap
- EUR 128M
- P/E
- -
- P/B
- 1.74x
- ROE
- -45.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is TED.F undervalued?
Graham numberThe Graham number of TerrAscend Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
TerrAscend Corp fundamental analysis
No fundamental analysis for TerrAscend Corp yet.
TerrAscend Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About TerrAscend Corp
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States. The company manufactures vaporizables, concentrates, topicals, flowers, tinctures, and edibles. It offers its products under the brand name Kind Tree Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, and Cookies. The company also operates retail dispensaries under the Apothecarium brand name. It serves medical patients and adult-use consume…
Full company profileTerrAscend Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
TerrAscend Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 0.00 | 0.00 | 6.83M | 84.9M | 198M | 210M | 248M | 251M | 268M | 261M | 268M |
| Gross Profit | 0.00 | -137K | -1.75M | 8.33M | 145M | 112M | 102M | 138M | 136M | 136M | 142M |
| Operating Income | -867K | -6.66M | -27.1M | -59.6M | 59.7M | 23.5M | -14.3M | 50.0M | 41.4M | 44.6M | 45.2M |
| EBITDA | - | -6.41M | -26.2M | -204M | -95.8M | 77.1M | -247M | 43.9M | 54.8M | 58.5M | 71.2M |
| Net Income | -867K | -6.81M | -22.0M | -216M | -155M | 3.11M | -304M | -95.5M | -80.2M | -86.2M | -33.1M |
| EPS | - | -0.07 | -0.29 | -1.52 | -1.00 | 0.01 | -1.18 | -0.33 | -0.27 | -0.28 | -0.11 |
| Balance Sheet | |||||||||||
| Total Assets | 3.87M | 69.1M | 89.0M | 461M | 604M | 582M | 702M | 667M | 607M | 557M | 558M |
| Total Liabilities | 1.79M | 1.69M | 31.1M | 385M | 593M | 353M | 380M | 426M | 430M | 458M | 479M |
| Shareholders' Equity | 2.08M | 67.4M | 56.5M | 66.7M | 1.19M | 224M | 319M | 242M | 177M | 97.5M | 73.1M |
| Cash & Short-term Investments | 3.33M | 51.8M | 21.8M | 11.9M | 75.4M | 79.6M | 26.2M | 22.2M | 26.4M | 37.4M | 42.5M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -423K | -4.15M | -20.2M | -39.8M | -37.0M | -31.8M | -26.1M | 27.5M | 38.0M | 21.5M | 31.9M |
| Capital Expenditure | 4.27K | 14.1M | 8.63M | 32.8M | 43.8M | 39.8M | 39.6M | 9.43M | 8.05M | 9.35M | 6.98M |
| Free Cash Flow | - | -18.5M | -37.9M | -93.0M | -28.1M | -72.7M | -68.0M | 18.0M | 29.9M | 12.2M | 24.9M |
| Ratios | |||||||||||
| ROE | -41.7% | -10.1% | -39.0% | -323.6% | -13,068.5% | 1.4% | -95.3% | -39.4% | -45.3% | -88.5% | -45.3% |
| ROA | -22.4% | -9.9% | -24.8% | -46.8% | -25.7% | 0.5% | -43.3% | -14.3% | -13.2% | -15.5% | -5.9% |
| Net Profit Margin | - | - | -322.7% | -254.3% | -78.2% | 1.5% | -122.6% | -38.1% | -29.9% | -33.1% | -12.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
TerrAscend Corp dividends
TerrAscend Corp has not paid dividends in the last 9 fiscal years.
Who owns TerrAscend Corp
- Insiders 5.47%
- Institutions 13.84%
- Public & others 80.69%
- Shares outstanding 309M
- Free float 221M
TerrAscend Corp company profile
- Company name
- TerrAscend Corp
- Ticker
- TED.F
- ISIN
- CA88105E1088
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 828
- Fiscal year end
- December
- Address
- 77 City Centre Drive, East Tower, Mississauga, ON, Canada, L5B 1M5
- Phone
- 717 610 4165
- Website
- terrascend.com
About TerrAscend Corp
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States. The company manufactures vaporizables, concentrates, topicals, flowers, tinctures, and edibles. It offers its products under the brand name Kind Tree Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, and Cookies. The company also operates retail dispensaries under the Apothecarium brand name. It serves medical patients and adult-use consumers in North America. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.
TerrAscend Corp management
8- Mr. Jason Garrett Wild R.Ph.Executive Chairman · born 1973
- Mr. Ziad GhanemPresident, CEO & Director · born 1977
- Ms. Lynn Gefen J.D.Chief People Officer, Chief Legal Officer & Corporate Secretary · born 1971
- Mr. Eric JacksonChief Financial Officer
- Ms. Alisa CampbellSVP of Corporate Finance & Accounting
- Mr. David WheelerSenior VP & Chief Information Officer
- Mr. BJ CarrettaSenior Vice President of Marketing
- Michelle NelsonSenior Counsel